| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |